The effects of daily low-dose aspirin on white matter hyperintensity lesions and retinal vascular calibre in healthy older adults: the ENVIS-ion exploratory neuroimaging substudy of the ASPREE randomised clinical trial
Authors
C. Reid
Katherine L. Webb (ORCID: https://orcid.org/0000-0002-9380-6075)
Walter P. Abhayaratna (ORCID: https://orcid.org/0000-0002-4908-0641)
Liubov D. Robman (ORCID: https://orcid.org/0000-0002-6207-5599)
Scott Kolbe (ORCID: https://orcid.org/0000-0003-4685-1380)
The effects of daily low-dose aspirin on white matter hyperintensity lesions and retinal vascular calibre in healthy older adults: the ENVIS-ion exploratory neuroimaging substudy of the ASPREE randomised clinical trial
C. Reid, Katherine L. Webb, Walter P. Abhayaratna, Liubov D. Robman et al.
Journal
The Lancet Healthy Longevity
Topics
Retinal Diseases and Treatments
article
The effects of daily low-dose aspirin on white matter hyperintensity lesions and retinal vascular calibre in healthy older adults: the ENVIS-ion exploratory neuroimaging substudy of the ASPREE randomised clinical trial
C. Reid, Katherine L. Webb, Walter P. Abhayaratna, Liubov D. Robman, Scott Kolbe, Ben Sinclair, AM Tonkin, Robyn L. Woods, John J. McNeil, M. Law, Rory Wolfe, Stephanie A Ward, Ruth E Trevaks, Tien Y Wong, Elsdon Storey, Marc M Budge
article en
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Healthy LongevityVol. 7(2)
Institutions
Australian National University (AU), Curtin University (AU), Singapore National Eye Center (SG), UNSW Sydney (AU), Centre for Eye Research Australia (AU), Bendigo Health (AU), Bendigo Hospital (AU), Monash University (AU)